Literature DB >> 21554393

Surgical infection prophylaxis for left ventricular assist device implantation.

Paul C Walker1, Daryl D DePestel, Nicholas A Miles, Preeti N Malani.   

Abstract

BACKGROUND: Antimicrobial prophylaxis is commonly administered to patients undergoing left ventricular assist device (LVAD) surgeries to prevent infectious complications. However, optimal surgical infection prophylaxis (SIP) for LVAD surgeries is not well defined.
METHODS: We conducted an electronic survey to characterize LVAD SIP used at different centers performing LVAD implantation.
RESULTS: Responses were received from 23 of 85 centers (27%). Of 21 centers that provided usable data about their LVAD SIP regimens for nonpenicillin allergic patients, 42.9% reported using a four-drug regimen (three antibiotics plus fluconazole), 23.8% reported using a three-drug regimen (three antibiotics or two antibiotics plus fluconazole), 23.8% reported using a regimen of two antibiotics, and 9.5% reported using vancomycin alone. A similar pattern was observed among SIP regimens for penicillin-allergic patients. Criteria for discontinuation of SIP and use of decolonization strategies also varied widely across centers.
CONCLUSIONS: Our results demonstrate wide variability in LVAD SIP regimens and underscore the lack of consensus regarding best practice.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554393     DOI: 10.1111/j.1540-8191.2011.01262.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  9 in total

Review 1.  Impact of adverse events on ventricular assist device outcomes.

Authors:  Aleksandar Adzic; Snehal R Patel; Simon Maybaum
Journal:  Curr Heart Fail Rep       Date:  2013-03

2.  Infectious Complications of Mechanical Circulatory Support (MCS) Devices.

Authors:  Stanley I Martin
Journal:  Curr Infect Dis Rep       Date:  2013-09-29       Impact factor: 3.725

3.  Single Versus Multidrug Regimen for Surgical Infection Prophylaxis in Left Ventricular Assist Device Implantation.

Authors:  Nana Aburjania; Brennan M Ertmer; Saira Farid; Melody Berg; Juhsien J C Nienaber; Vakhtang Tchantchaleishvili; John M Stulak; Larry M Baddour; Muhammad R Sohail
Journal:  ASAIO J       Date:  2018 Nov/Dec       Impact factor: 2.872

4.  Ventricular assist device infections.

Authors:  Denis Spelman; Donald Esmore
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 5.  Clinical pharmacology considerations for children supported with ventricular assist devices.

Authors:  Jennifer Sherwin; Elizabeth Thompson; Kevin D Hill; Kevin Watt; Andrew J Lodge; Daniel Gonzalez; Christoph P Hornik
Journal:  Cardiol Young       Date:  2018-07-11       Impact factor: 1.093

Review 6.  In Full Flow: Left Ventricular Assist Device Infections in the Modern Era.

Authors:  Radoslav Zinoviev; Christopher K Lippincott; Sara C Keller; Nisha A Gilotra
Journal:  Open Forum Infect Dis       Date:  2020-04-17       Impact factor: 3.835

7.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

8.  In vitro Evaluation of Medihoney Antibacterial Wound Gel as an Anti-biofilm Agent Against Ventricular Assist Device Driveline Infections.

Authors:  Yue Qu; David McGiffin; Christina Kure; Janelle McLean; Courtney Duncan; Anton Y Peleg
Journal:  Front Microbiol       Date:  2020-11-23       Impact factor: 5.640

Review 9.  Ventricular Assist Device-Specific Infections.

Authors:  Yue Qu; Anton Y Peleg; David McGiffin
Journal:  J Clin Med       Date:  2021-01-25       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.